MedTrace Logo

Multiple Ascending Dose Study for AZD 7268 in Japanese Healthy Male Volunteers

NCT01116011 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 30

Last updated 2010-12-15

No results posted yet for this study

Summary

This is a multiple ascending dose study (MAD) in the Japanese population with AZD7268. This MAD study will evaluate the safety, tolerability and pharmacokinetics of orally administered AZD7268 after multiple ascending doses.

Conditions

  • Healthy

Interventions

DRUG

AZD7268

Capsule, Oral, BID

DRUG

Placebo

Capsule, Oral, BID

Sponsors & Collaborators

Principal Investigators

  • Tomoe Fujita · Kitasato University East Hospital, Kanagawa, Japan

Study Design

Allocation
RANDOMIZED
Masking
QUADRUPLE
Model
SINGLE_GROUP

Eligibility

Min Age
20 Years
Max Age
45 Years
Sex
MALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2010-04-30
Primary Completion
2010-07-31
Completion
2010-07-31

Countries

  • Japan

Study Locations

More Related Trials

Entities

Drugs
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01116011 on ClinicalTrials.gov